rs147993402

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6BP7BS2

The NM_001940.4(ATN1):​c.408C>T​(p.Tyr136Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00738 in 1,614,012 control chromosomes in the GnomAD database, including 64 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0048 ( 4 hom., cov: 31)
Exomes 𝑓: 0.0076 ( 60 hom. )

Consequence

ATN1
NM_001940.4 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:2

Conservation

PhyloP100: 0.987

Publications

2 publications found
Variant links:
Genes affected
ATN1 (HGNC:3033): (atrophin 1) Dentatorubral pallidoluysian atrophy (DRPLA) is a rare neurodegenerative disorder characterized by cerebellar ataxia, myoclonic epilepsy, choreoathetosis, and dementia. The disorder is related to the expansion from 7-35 copies to 49-93 copies of a trinucleotide repeat (CAG/CAA) within this gene. The encoded protein includes a serine repeat and a region of alternating acidic and basic amino acids, as well as the variable glutamine repeat. Alternative splicing results in two transcripts variants that encode the same protein. [provided by RefSeq, Jul 2016]
ATN1 Gene-Disease associations (from GenCC):
  • congenital hypotonia, epilepsy, developmental delay, and digital anomalies
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Illumina, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • dentatorubral-pallidoluysian atrophy
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.65).
BP6
Variant 12-6935675-C-T is Benign according to our data. Variant chr12-6935675-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 210378.
BP7
Synonymous conserved (PhyloP=0.987 with no splicing effect.
BS2
High AC in GnomAd4 at 738 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATN1NM_001940.4 linkc.408C>T p.Tyr136Tyr synonymous_variant Exon 5 of 10 ENST00000396684.3 NP_001931.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATN1ENST00000396684.3 linkc.408C>T p.Tyr136Tyr synonymous_variant Exon 5 of 10 1 NM_001940.4 ENSP00000379915.2
ATN1ENST00000356654.8 linkc.408C>T p.Tyr136Tyr synonymous_variant Exon 5 of 10 1 ENSP00000349076.3

Frequencies

GnomAD3 genomes
AF:
0.00485
AC:
738
AN:
152110
Hom.:
4
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00184
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00445
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00132
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00828
Gnomad OTH
AF:
0.00527
GnomAD2 exomes
AF:
0.00436
AC:
1095
AN:
251382
AF XY:
0.00414
show subpopulations
Gnomad AFR exome
AF:
0.00154
Gnomad AMR exome
AF:
0.00344
Gnomad ASJ exome
AF:
0.00218
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00180
Gnomad NFE exome
AF:
0.00754
Gnomad OTH exome
AF:
0.00538
GnomAD4 exome
AF:
0.00764
AC:
11166
AN:
1461784
Hom.:
60
Cov.:
38
AF XY:
0.00737
AC XY:
5363
AN XY:
727214
show subpopulations
African (AFR)
AF:
0.00152
AC:
51
AN:
33480
American (AMR)
AF:
0.00333
AC:
149
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.00253
AC:
66
AN:
26128
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86258
European-Finnish (FIN)
AF:
0.00172
AC:
92
AN:
53418
Middle Eastern (MID)
AF:
0.000694
AC:
4
AN:
5764
European-Non Finnish (NFE)
AF:
0.00935
AC:
10396
AN:
1111942
Other (OTH)
AF:
0.00674
AC:
407
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
663
1326
1988
2651
3314
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
402
804
1206
1608
2010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00485
AC:
738
AN:
152228
Hom.:
4
Cov.:
31
AF XY:
0.00458
AC XY:
341
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.00183
AC:
76
AN:
41524
American (AMR)
AF:
0.00444
AC:
68
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5166
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
0.00132
AC:
14
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00828
AC:
563
AN:
67994
Other (OTH)
AF:
0.00521
AC:
11
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
37
74
112
149
186
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00669
Hom.:
2
Bravo
AF:
0.00480
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00812
EpiControl
AF:
0.00872

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ATN1: BP4, BP7, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 22, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Uncertain:1
Jun 27, 2014
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.65
CADD
Benign
9.3
DANN
Benign
0.86
PhyloP100
0.99
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs147993402; hg19: chr12-7044838; API